$ACMR

McKechnie Mark sold $4.3M of ACMR

McKechnie Mark (See Remarks) sold 55,199 shares of ACM Research, Inc. (ACMR) at an average of $77.27 ($76.34–$77.89, $4.26M total) across 3 trades on 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McKechnie Mark
Published Aug 22, 2026, 1:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 1:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Bearish
medium confidence
Mentioned
$ACMR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRBearishLow
01

Why it matters

The insider sale reduces insider ownership, which some traders view as a bearish signal.

02

Market read

Insider sell of $4.3M may influence short-term price action for ACMR.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 5/10Timing: filed after market close on 2026-08-21

Background

Form 4 filings provide the first public disclosure of insider transactions.

Company-level read

Ticker impact

$ACMRBearishMedium confidence
Context

Officer Mark McKechnie sold 55,199 shares for $4.3M via a 10b5-1 plan, reducing his stake to 900 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size ($4.3M) is material for a small-cap and executed under a pre-arranged plan, suggesting a neutral to slightly bearish signal.

Market effects

Minimal impact on the broader semiconductor equipment sector.

Limited to U.S. investors tracking insider activity.

Low

Counterpoint

The 10b5-1 plan may have been pre-scheduled, not reflecting current sentiment.

Key entities

  • ACM Research, Inc.

    Semiconductor equipment manufacturer.

  • Mark McKechnie

    Company officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$ACMRMed

ACM Research (NASDAQ: ACMR) unit’s orders surge past 100% with 42–48% margin outlook

ACM Research (Shanghai) reported a 105% year-over-year increase in new orders for the first half of 2026, with growth across electroplating, cleaning, and advanced packaging equipment. The company expects gross margins to remain between 42% and 48%. Significant orders include panel-level electroplating systems for delivery in 2026 and 2027. ACM Shanghai also highlighted rapid growth in mature-node semiconductor manufacturing and AI-related equipment demand.

$ACMRMedAI 9/10

ACM Research (ACMR) Q2 2026 Earnings Call Transcript

ACM Research (ACMR) reported Q2 2026 revenue of $292.9M, up 36% year over year, with non-GAAP diluted EPS of $0.61. Non-GAAP gross margin was 46.0%. The company raised 2026 revenue guidance to $1.125B-$1.175B and said first-half orders rose 105%. Net cash was $1.0B.